New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:04 EDTTTEK, TOT, MXWL, AGN, WBK, RENT, SSW, ESI, IBM, STO, PXD, FRXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Buy from Neutral at SunTrust... American Express (AXP) upgraded to Positive from Neutral at Susquehanna ... Forest Labs (FRX) upgraded to Outperform from Neutral at Credit Suisse... ITT Educational (ESI) upgraded to Buy from Neutral at BofA/Merrill... Maxwell (MXWL) upgraded to Overweight from Neutral at Piper Jaffray... Pioneer Natural (PXD) upgraded to Buy from Hold at Stifel... Seaspan (SSW) upgraded to Hold from Sell at Stifel... Statoil (STO) upgraded to Buy from Hold at Deutsche Bank... Total (TOT) upgraded to Buy from Neutral at Citigroup... Rentrak (RENT) upgraded to Market Perform from Underweight at Albert Fried... IBM (IBM) upgraded to Buy from Outperform at CLSA... Tetra Tech (TTEK) upgraded to Overweight from Equal Weight at Stephens... Westpac Banking (WBK) upgraded to Neutral from Sell at Goldman.
News For AGN;FRX;ESI;MXWL;PXD;SSW;TOT;STO;RENT;TTEK;IBM;WBK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 28, 2015
15:12 EDTTOTTotal volatility elevated as WTI oil above $45
Subscribe for More Information
09:50 EDTAGNAllergan plans for generic version of Endo's Fortesta blocked, Bloomberg reports
A judge upheld Endo's (ENDP) patents on Fortesta expiring in 2018 and blocked Allergan's (AGN) bid to launch a generic version of the testosterone gel, according to Bloomberg.
09:02 EDTIBMIBM and GENCI announce collaboration
Subscribe for More Information
August 27, 2015
13:49 EDTIBMIBM volatility elevated on wide price movement
IBM current 30-day call option implied volatility is at 23, compared to a one-month ago level of 18, suggesting large price movement.
10:11 EDTRENTRentrak management to meet with Needham
Meeting to be held in Boston on September 3 hosted by Needham.
07:57 EDTSTOPlatts to hold a conference
Subscribe for More Information
05:32 EDTTOTTotal sells North Sea midstream assets for $905M
Subscribe for More Information
August 26, 2015
08:40 EDTIBMIBM upgraded to Buy at Argus on valuation, easier comps
Subscribe for More Information
07:44 EDTIBMIBM upgraded to Buy from Hold at Argus
Subscribe for More Information
August 25, 2015
08:16 EDTESICalifornia drops attempt to suspend ITT Tech
Subscribe for More Information
08:14 EDTAGNAllergan multiple is low, says Leerink
Leerink predicts that Allergan's 2016 EPS will come in at $17-$18. The firm thinks the company has "durable revenue streams," and a "deep pipeline with several potential blockbuster candidates." Leerink adds that the company "has significant capacity for M&A." It keeps a $388 price target and Outperform rating on the shares.
07:24 EDTRENTRentrak weakness a buying opportunity, says Brean Capital
Subscribe for More Information
August 24, 2015
08:37 EDTAGNAllergan recalls certain lots of REFRESH, FML, Blephamide treatments
Allergan announced that it is conducting a voluntary recall down to consumer level of specific lots of its REFRESH Lacri-Lube 3.5g and 7g for dry eye, REFRESH P.M. 3.5g for dry eye, FML 0.1%, and Blephamide 10%/0.2% sterile topical ophthalmic ointment combining an antibacterial and a corticosteroid, 3.5g. Allergan chose to initiate this recall based on a small number of customer complaints which reported a small black particle at the time of use. Allergan has informed the U.S. Food and Drug Administration of this voluntary recall. Allergan is contacting retailers and wholesalers who have been shipped affected product lots to initiate the recall and is informing them of the steps needed to return affected product.
August 23, 2015
17:49 EDTTOTIran to increase oil production as BP, Shell express interest, Bloomberg says
Subscribe for More Information
August 21, 2015
12:13 EDTIBMBrocade soars after Q3 results top estimates
Subscribe for More Information
06:01 EDTIBMABI Research: Portable PC sales to remain flat in 2015, DigiTimes says
Subscribe for More Information
August 20, 2015
18:07 EDTIBMBrocade seeing pressure in server business due to IBM-Lenovo deal
Brocade (BRCD) says "where we've really seen pressure has been in our server related business," due to market conditions as well as divestiture of IBM's (IBM) commodity business to Lenovo (LNVGY). Says growth of flash storage continues to be one of the "most disruptive" factors in data center. Comments taken from Q3 earnings conference call.
08:16 EDTAGNAllergan's Botox resubmission for lower limb spasticiy accepted by FDA
Allergan 's resubmission of its Supplemental Biologics License Application for Botox for the treatment of adults with lower limb spasticity in adults has been accepted by the FDA. A six-month review period has been assigned for the sBLA. The Prescription Drug User Fee Act date is expected to be in 1Q16. The resubmission provides additional data from a double-blind, placebo controlled study involving 468 patients with lower limb spasticity. The FDA also approved an increase to the maximum Botox cumulative dose within three months from 360 to 400 units in adults treated for one or more indications.
07:07 EDTRENTRentrak announces partnership with MovieTickets.com
Subscribe for More Information
06:10 EDTTOTAuction for drilling leases attracts little interest, NY Times reports
A federal auction for drilling leases in the Gulf of Mexico Wednesday attracted only $22.7M in sales from five companies, the lowest since 1986, reports the New York Times. Most companies have insisted they would not sacrifice production in future years, but executives have recently expressed concern that the oil price collapse could last through 2016 and possibly even 2017. Publicly traded companies in the space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Reference Link
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use